Joe and The Gene: A Mother's Perspective
By Lia Tremblay,
NPR
| 04. 09. 2020
Joe has my nose, his father’s eyes, and facial expressions that mirror those of his grandfathers. But the unexpected “misspelling” coiled up in his DNA has also given us a child we could never have imagined—and would never want to replace.
Seeing Thomas Hunt Morgan’s experiments with fruit flies in episode one of The Gene: An Intimate History took me right back to ninth grade biology. My entire class of 14-year-olds paired up to carefully sedate swarms of fruit flies and group them according to their physical characteristics. Then we matched them up for mating and inspected their offspring to see which eye colors, stripe patterns and wing shapes had passed down to the new generation.
For many years, that was the extent of my interest in genetics.
Then came Joe. The only child of my husband and me, Joe is 11 years old, laughs a lot and loves to dance. Like a lot of 11-year-olds, he spends too much time on his iPad, ignores our directions and dawdles over dinner.
But Joe is also very different from most of his peers. He speaks only a few words, learns new things at a leisurely pace, needs help with tasks like climbing steps and opening doors, and is about the size of a child half his age.
Like Susannah, the...
Related Articles
By Matthew Ormseth and Summer Lin, Los Angeles Times | 10.02.2025
The father of some 22 children discovered by Arcadia police in May also owns a property in El Monte where authorities found evidence of illegal gambling and drug activity, court records show.
Guojun Xuan, 65, told detectives all but two...
By Emma Belmonte, ChinaFile | 10.03.2025
On the popular Chinese social media platform Xiaohongshu, also known as RedNote, an account called “Georgia Notes” (@格鲁吉亚小纸条) offers tips and advice to Chinese nationals planning a trip to the Republic of Georgia. In one post...
By Jared Whitlock, Endpoints News | 10.09.2025
When Nirnay Murthy learned about a treatment for his toddler son’s rare condition, relief quickly gave way to disappointment.
A one-time gene therapy called Zolgensma from the Swiss drugmaker Novartis can halt spinal muscular atrophy, a deadly condition that causes...
By Claire Robinson, GMWatch | 09.29.2025
According to an article on BBC News, the Quadram Institute in Norwich is recruiting 76 people with low vitamin D to take part in the ViTaL-D Study, where some participants will eat soup containing tomatoes that have been genetically...